drugset / Trial / NCT01799850
The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle
Phase 4
Completed
12 enrolled
East Tennessee State University
Takeda Pharmaceuticals North America, Inc. · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Subjects with type 2 diabetes will be treated with Actos or placebo for eight weeks and needle biopsies of muscle will quantify changes in any of seven different glucose transport proteins in muscle.
Timeline
- Start
- 2002-03
- Primary completion
- 2004-03
- Completion
- 2004-03
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pioglitazone | Small molecule | 30 mg | Oral |